Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters
Descrição
In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.
Cross protection to SARS-CoV-2 variants in hamsters with naturally
A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress
Frontiers Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2
Post-acute sequelae of COVID-19: A metabolic perspective
Role of the humoral immune response during COVID-19: guilty or not
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2
The impact of pre-existing cross-reactive immunity on SARS-CoV-2
A single intranasal or intramuscular immunization with chimpanzee
Vaccines, Free Full-Text
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike
How Protective are Antibodies to SARS-CoV-2, the Main Weapon of
Cross protection to SARS-CoV-2 variants in hamsters with naturally
Resources for Health Professionals
de
por adulto (o preço varia de acordo com o tamanho do grupo)
